Atsuhiko Yagishita

Dr. Atsuhiko Yagishita

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 May 2017 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
PDF file
AYAtsuhiko Yagishita
Atsuhiko Yagishita
DSDina Sparano
Dina Sparano
ICIvan Cakulev
Ivan Cakulev
JGJ. Rod Gimbel
J. Rod Gimbel
TPTimothy Phelan
Timothy Phelan
MAMauricio Arruda
Mauricio Arruda

1 January 2011 in Circulation Journal
Verified
Journal Article
Open access
PDF file
AYAtsuhiko Yagishita
Atsuhiko Yagishita
YTYoshihide Takahashi
Yoshihide Takahashi
ATAtsushi Takahashi
Atsushi Takahashi
AFAkira Fujii
Akira Fujii
SKShigeki Kusa
Shigeki Kusa
MIMitsuaki Isobe
Mitsuaki Isobe
Background: A low incidence of thromboembolic events after successful catheter ablation of atrial fibrillation (AF) during a mid-term follow-up period was recently reported. However, because the incidence of such events over the long term is unknown, we investigated the late incidence of thromboembolic events after catheter ablation. Methods and Results: Patients with paroxysmal and persistent AF undergoing catheter ablation and being followed up for at least 24 months formed the study group (n=524); 82 patients (16%) had CHADS2 scores of at least 2. Mean follow-up was 44±13 months. Warfarin was discontinued in 400 (93%) of 429 patients (82% of 524 patients) without AF recurrence. None of the patients without AF recurrence suffered thromboembolic events, whereas 3 of 95 patients (3%) with AF recurrence did (P12 months after catheter ablation. There were 2 nonfatal major hemorrhagic events in patients with AF recurrence who continued on warfarin, but no hemorrhagic events were observed in patients free from AF (P=0.002). Conclusions: Maintenance of sinus rhythm after catheter ablation of AF was associated with a lower incidence of thromboembolic events during long-term follow-up >3 years. This result suggests that catheter ablation reduces thromboembolic events if patients continue anticoagulation regardless of the ablation outcome. (Circ J 2011; 75: 2343-2349)

1 January 2017 in Circulation Journal
Verified
Journal Article
Open access
PDF file
AYAtsuhiko Yagishita
Atsuhiko Yagishita
YYYasuteru Yamauchi
Yasuteru Yamauchi
HSHironori Sato
Hironori Sato
SYShu Yamashita
Shu Yamashita
THTatsuhiko Hirao
Tatsuhiko Hirao
MIMitsuaki Isobe
Mitsuaki Isobe
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societies

25 November 2019 in Journal of Cardiovascular Electrophysiology
Verified
Journal Article
Closed access
YTYoshihide Takahashi
Yoshihide Takahashi
KAKikou Akiyoshi
Kikou Akiyoshi
MSMasahiko Sekigawa
Masahiko Sekigawa
AYAtsuhiko Yagishita
Atsuhiko Yagishita
TYTasuku Yamamoto
Tasuku Yamamoto
TSTetsuo Sasano
Tetsuo Sasano

1 September 2011 in Journal of Cardiology
Verified
Journal Article
Open access
PDF file
MKMihoko Kawabata
Mihoko Kawabata
KHKenzo Hirao
Kenzo Hirao
HHHitoshi Hachiya
Hitoshi Hachiya
KHKouji Higuchi
Kouji Higuchi
YTYasuaki Tanaka
Yasuaki Tanaka
MIMitsuaki Isobe
Mitsuaki Isobe
Effective rhythm control of atrial fibrillation (AF) frequently bestows clinically meaningful advantages, such as increased exercise tolerance, improvement in symptoms, and prevention of atrial remodeling. The incidence of AF increases with the onset of congestive heart failure (CHF) and rhythm control is attempted in patients with AF and CHF in practice [ 1 x [1] The National Heart, Lung, and Blood Institute Working Group on Atrial Fibrillation. Atrial fibrillation: current understanding and research imperatives. J Am Coll Cardiol. 1993; 22: 1830–1834 Abstract | Full Text PDF | PubMed | Scopus (107) | Google Scholar See all References , 2 x [2] Waldo, A.L. Management of atrial fibrillation: the need for AFFIRMative action. Am J Cardiol. 1999; 84: 698–700 Abstract | Full Text PDF | PubMed | Scopus (35) | Google Scholar See all References ].

16 March 2022 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Open access
PDF file
SSSusumu Sakama
Susumu Sakama
AYAtsuhiko Yagishita
Atsuhiko Yagishita
TSTetsuri Sakai
Tetsuri Sakai
MMMasahiro Morise
Masahiro Morise
KAKengo Ayabe
Kengo Ayabe
KYKoichiro Yoshioka
Koichiro Yoshioka
Purpose: The feasibility and safety of cavotricuspid isthmus (CTI) ablation with contiguous lesions using ablation index (AI) under the guidance of fluoroscopy integrated 3D mapping (CARTO UNIVU/CU) in typical atrial flutter (AFL) remains uncertain. This study aimed to determine the efficacy of AI-guided CTI ablation with contiguous lesions in patients with AFL. Methods: In this single-center, prospective, non-randomized, single-arm, observational study, procedural outcomes were determined in 151 patients undergoing AI-guided CTI ablation (AI group) with a target AI value of 450 and an interlesion distance of ≤ 4 mm under CU guidance. These outcomes were compared with those of 30 patients undergoing non-AI-guided ablation (non-AI group). Results: Among 151 patients, first-pass conduction block was achieved in 120 (80%) patients in the AI group (67% in the non-AI group, P = 0.152) with a shorter fluoroscopy time of 0.2 ± 0.4 min (1.7 ± 2.0 min in the non-AI group, P < 0.001). Conduction gaps were located at the atrial aspects near the inferior vena cava in 24 of 31 (78%) patients without first-pass conduction block. The AI group received 11 ± 5 (12 ± 4 in the non-AI group, P = 0.098) radiofrequency (RF) applications, and the RF time was 4.2 ± 2.4 (5.1 ± 2.5 min in the non-AI group, P = 0.011). Despite the occurrence of steam pop in 3 (2%) patients, none of them developed cardiac tamponade. No patients had recurrence within 6 months of follow-up. Conclusions: AI-guided CTI ablation in combination with CU was feasible and effective in reducing radiation exposure in patients with AFL.